27 May 2021

This 4th European PhD and Postdoc symposium “EXPLORING LIFE DYNAMICS: In and out of equilibrium”, organized by and for young researchers, was held completely online. ENABLE aims to involve young scientists in opening the academic world from within by promoting crosstalk between biomedical disciplines, collaboration with industry, and engagement with society. ENABLE 2021 took place in Milan, albeit this year of course only virtually. Again, this year was a great success.

ENABLE (European Academy for Biomedical Science) is an initiative funded by the European Union Horizon 2020 programme that involves four renowned European Research Institutes (IRB Barcelona – Spain, RIMLS – Netherlands, NNF CPR – Denmark, SEMM – Italy) and an innovative science communication agency (Scienseed). ENABLE seeks to promote excellence in the biomedical sciences in Europe: supporting young researchers, strengthening scientific careers, and bringing biomedicine closer to society.

Poster awards ENABLE for Kest Verstappen and Daan 't Hart

59 posters were presented online during the conference. Kest Verstappen (theme Reconstructive and Regenerative Medicine) and Daan ’t Hart (theme Renal disorders) each won the prize for their poster session. Kest presented his poster entitled “Graphene-based biomaterials as potential inhibitors of astrogliosis”. Congratulations to Kest, Frank Walboomers (PhD promotor) and Sander Leeuwenburgh (head Regenerative Biomaterials)! Daan’s poster presentation carried the title ”Say NO to podocyte injury: An (e)NOS-NO-sGC-cGMP-TRPC6 pathway as putative novel treatment target” and was highly valued by the jury and other participants. Daan is a PhD candidate in the group of Johan van der Vlag and Tom Nijenhuis.

This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement n° 724115) 

Related news items


New ultra-high field MRI system available for Radboudumc and Radboud University

10 June 2021

Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.

read more

On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis

10 June 2021

Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.

read more

Retina-on-chip modeling and treating eye diseases in a dish

10 June 2021

Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.

read more

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses

8 June 2021

Jeroen Creemers and Johannes Textor published in the Journal for ImmunoTherapy of Cancer that a tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.

read more

New method to prevent ovarian cancer increases quality of life

8 June 2021

Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.

read more

Radboud Pluim for Dagmar Eleveld-Trancikova Policy advisor of the three research institutes

8 June 2021

Radboudpluim for research policy adviser Dagmar Eleveld-Trancikova.

read more